Therefore, considering the increased expression of MMP-2 and TIMP-1 in COPD patients and their association with collagen and elastic fiber formation, MMP-2 appears to be involved in ECM remodeling and interstitial fibrosis and to be a suitable therapeutic target for COPD pathogenesis [100]. This evidence concerns the gene TIMP1 and chronic obstructive pulmonary disease.